Dehydroascorbic acid
|
Basic information |
| Metabolite name | Dehydroascorbic acid |
 | HMDB0001264 |
 |
C00425 |
 |
440667 |
| Synonyms | NA |
| No. of studies | 8 |
|
Basic information |
| Metabolite name | Dehydroascorbic acid |
| HMDB0001264 |
|
C00425 |
|
440667 |
| Synonyms | NA |
| No. of studies | 8 |
|
Relationship between Dehydroascorbic acid and depression (count: 8) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M042 | Type3 | fluoxetine group vs. control group | Plasma | Rhesus monkey | Up |
| Study M045 | Type1 | CUMS group vs. control group | Peripheral blood mononuclear cell | Sprague-Dawley rat | Down |
| Study M129 | Type3 | venlafaxine group vs. control group | Hippocampus | C57BL/6J mouse | Down |
| Study M463 | Type3 | venlafaxine group vs. control group | Prefrontal cortex | C57BL/6J mouse | Up |
| Study M630 | Type2 | acupuncture + antidepressant group, post vs. before treatment | Urine | Human | Up |
| Study M846 | Type2 | postpartum depression model + 919 syrup group vs. postpartum depression model group | Hippocampus | BALB/c mouse | Down |
| Study M882 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M953 | Type1 | CRS group vs. control group | Faece | Sprague-Dawley rat | Up |